Transmembrane protein 210 (TMEM210)
Homo sapiens — UniProt A6NLX4
Data last refreshed: (UniProt release unknown)
Key facts
Transmembrane protein 210 (TMEM210) is a protein from Homo sapiens identified by UniProt accession A6NLX4, 147 residues long. MolForge cross-references it against 0 known binders and 1 disease associations.
- UniProt accession: A6NLX4; gene symbol TMEM210.
- Organism: Homo sapiens.
- Length: 147 amino acids.
- Top disease associations (Open Targets): gestational diabetes.
- 3D structure: AlphaFold model available.
Target properties
| Protein name | Transmembrane protein 210 |
|---|---|
| UniProt accession | A6NLX4 |
| Gene | TMEM210 |
| Organism | Homo sapiens |
| Length | 147 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | — |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|---|
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1)
Diseases linked to this target (Open Targets).
- gestational diabetes · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|---|---|---|---|
| AF-A6NLX4-F1 | alphafold | PREDICTED | 61.08 | — |
Experimental structures are not indexed in MolForge yet — search RCSB PDB for A6NLX4.
Amino-acid sequence (147 residues)
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
Which diseases are associated with TMEM210?
The strongest Open Targets associations for TMEM210 are gestational diabetes.
How long is the TMEM210 protein?
The Homo sapiens TMEM210 protein (UniProt A6NLX4) is 147 amino acids long.
Browse: Targets: T · all protein targets A–Z · drugs A–Z.
Sources
- UniProtKB A6NLX4 — name, gene, function, sequence, keywords (CC BY 4.0)
- AlphaFold DB A6NLX4 — predicted 3D structure (CC BY 4.0)
- Open Targets Platform — disease associations and tractability (CC0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.